FDA Panel Votes to Keep Diabetes Drug on Market - New York Times


NBC Sandiego.com		 FDA Panel Votes to Keep Diabetes Drug on Market
New York Times -2 hours ago
By GARDINER HARRIS GAITHERSBURG, Md., July 30 - A federal drug advisory committee voted 20 to 3 late this afternoon that Avandia, a controversial diabetes drug made by GlaxoSmithKline, raises the risks of heart attacks, but it then voted 22 to 1 that …
US.. panel weighs future of Glaxo diabetes drugScientific American
FDA Panel to Decide Avandia's FateABC News
Washington Post - Houston Chronicle - International Herald Tribune - Lawyers and Settlements
all 903 news articles

More: continued here

Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • De.lirio.us
  • digg
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Shadows
  • Simpy
  • Smarking
  • Spurl
  • YahooMyWeb



   Posted in Health News    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.





No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment